Medicine and Dentistry
Psoriasis
100%
Vasculotropin A
80%
Therapeutic Procedure
70%
Patient
50%
Development
30%
Angiogenesis
20%
Serositis
10%
Plasma
10%
Eye Disease
10%
Diseases
10%
Psoriasis Vulgaris
10%
Genetic Predisposition
10%
Morbidity
10%
Vascularity
10%
Malignant Neoplasm
10%
Innate Immunity
10%
Plaque
10%
Quality of Life
10%
Antiangiogenic Therapy
10%
Disease Predisposition
10%
Motivation
10%
Adaptive Immunity
10%
Epithelium
10%
Dermatitis
10%
Disease Severity
10%
Immune System
10%
Psoriasis Area and Severity Index
10%
Environmental Factor
10%
Factor A
10%
Pharmacogenetic Testing
10%
Skin Defect
10%
Therapy Effect
10%
Endothelial Cell Growth Factor
10%
Disease Clearance
10%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriasis
100%
Vasculotropin A
80%
Diseases
10%
Psoriasis Vulgaris
10%
Genetic Predisposition
10%
Morbidity
10%
Inflammation
10%
Malignant Neoplasm
10%
Eye Disease
10%
Disease Predisposition
10%
Dermatitis
10%
Disease Severity
10%
Factor A
10%
Skin Defect
10%
Endothelial Cell Growth Factor
10%
Disease Clearance
10%
Biochemistry, Genetics and Molecular Biology
Vascular Endothelial Growth Factor A
80%
Development
30%
Angiogenesis
20%
Genetics
10%
Innate Immunity
10%
Life
10%
Growth Factor
10%
Transgenics
10%
Experimental Model
10%
Motivation
10%
Vascularization
10%
Clearance
10%
Pharmacogenetic Testing
10%
Morbidity
10%
Adaptive Immunity
10%
Genetic Predisposition
10%
Antiangiogenic Activity
10%